These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 15940674

  • 21. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A, Palmieri G, Morrone S, Carretero M, Lopez-Botel M, Piccoli M, Frati L, Santoni A.
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [Abstract] [Full Text] [Related]

  • 22. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
    Warren HS, Rana PM, Rieger DT, Hewitt KA, Dahlstrom JE, Kent AL.
    J Leukoc Biol; 2006 Jun; 79(6):1252-9. PubMed ID: 16574769
    [Abstract] [Full Text] [Related]

  • 23. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M.
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [Abstract] [Full Text] [Related]

  • 24. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, Bardos P, Thibault G.
    J Immunol; 1999 May 15; 162(10):5902-9. PubMed ID: 10229826
    [Abstract] [Full Text] [Related]

  • 25. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
    Söderström K, Corliss B, Lanier LL, Phillips JH.
    J Immunol; 1997 Aug 01; 159(3):1072-5. PubMed ID: 9233599
    [Abstract] [Full Text] [Related]

  • 26. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A, Berg RE, Crossley E, Murray S, Forman J.
    Eur J Immunol; 2005 Mar 01; 35(3):766-75. PubMed ID: 15714583
    [Abstract] [Full Text] [Related]

  • 27. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.
    Fertil Steril; 2008 May 01; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [Abstract] [Full Text] [Related]

  • 28. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
    Wang Y, Zhu LP, Zhang W.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec 01; 24(6):653-5. PubMed ID: 12905700
    [Abstract] [Full Text] [Related]

  • 29. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L.
    Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1172-7. PubMed ID: 9448304
    [Abstract] [Full Text] [Related]

  • 30. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
    Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L, López-Botet M, González-Amaro R.
    Eur J Immunol; 2010 May 03; 40(5):1418-27. PubMed ID: 20201038
    [Abstract] [Full Text] [Related]

  • 31. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
    Wojtasiak M, Jones CM, Sullivan LC, Winterhalter AC, Carbone FR, Brooks AG.
    Int Immunol; 2004 Sep 03; 16(9):1333-41. PubMed ID: 15302848
    [Abstract] [Full Text] [Related]

  • 32. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD, Daley J, Ritz J, Robertson MJ.
    J Immunol; 1998 Feb 15; 160(4):1618-26. PubMed ID: 9469418
    [Abstract] [Full Text] [Related]

  • 33. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T, Kobayashi M, Asaka M, Imamura M.
    Exp Hematol; 2007 Oct 15; 35(10):1562-6. PubMed ID: 17681668
    [Abstract] [Full Text] [Related]

  • 34. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
    Saether PC, Hoelsbrekken SE, Fossum S, Dissen E.
    J Immunol; 2011 Dec 15; 187(12):6365-73. PubMed ID: 22084441
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A.
    Eur J Immunol; 1996 Oct 15; 26(10):2487-92. PubMed ID: 8898964
    [Abstract] [Full Text] [Related]

  • 37. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
    Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L.
    J Leukoc Biol; 2011 Jan 15; 89(1):75-84. PubMed ID: 20952657
    [Abstract] [Full Text] [Related]

  • 38. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG, Borrego F, Posch PE, Patamawenu A, Scorzelli CJ, Ulbrecht M, Weiss EH, Coligan JE.
    J Immunol; 1999 Jan 01; 162(1):305-13. PubMed ID: 9886400
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. How do NK cells sense the expression of HLA-G class Ib molecules?
    López-Botet M, Navarro F, Llano M.
    Semin Cancer Biol; 1999 Feb 01; 9(1):19-26. PubMed ID: 10092547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.